RUNDC1 Antikörper
-
- Target Alle RUNDC1 Antikörper anzeigen
- RUNDC1 (RUN Domain Containing 1 (RUNDC1))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser RUNDC1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Kreuzreaktivität
- Human
- Aufreinigung
- Purified by antigen-affinity chromatography.
- Immunogen
- Recombinant protein encompassing a sequence within the center region of human RUNDC1. The exact sequence is proprietary.
- Isotyp
- IgG
-
-
- Applikationshinweise
- WB: 1:500-1:3000. IHC-P: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
- Kommentare
-
Positive Control: HepG2
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- 1XPBS ( pH 7), 1 % BSA, 20 % Glycerol, 0.01 % Thimerosal
- Konservierungsmittel
- Thimerosal (Merthiolate)
- Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
- Target
- RUNDC1 (RUN Domain Containing 1 (RUNDC1))
- Andere Bezeichnung
- RUN domain containing 1 (RUNDC1 Produkte)
- Synonyme
- AW125546 antikoerper, D930024B17 antikoerper, RUN domain containing 1 antikoerper, RUNDC1 antikoerper, Rundc1 antikoerper
- Hintergrund
- RUN domain containing 1,May play a role as p53/TP53 inhibitor and thus may have oncogenic activity.
- Molekulargewicht
- 68 kDa
- Gen-ID
- 146923
-